Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Become EABM
Become Reviewer

Meet Our Section Editor free to download

Volume:20   Issue: 2
Pp: 85-85
A. Ilhan-Mutlu
DOI: 10.2174/156800962002200207092902

Nordihydroguaiaretic Acid in Therapeutics: Beneficial to Toxicity Profiles and the Search for its Analogs

Volume:20   Issue: 2
Pp: 86-103
Geraldine Sandana Mala John, Satoru Takeuchi, Ganesh Venkatraman* and Suresh Kumar Rayala*
DOI: 10.2174/1568009619666191022141547

Anti-tumor Activity of Propofol: A Focus on MicroRNAs

Volume:20   Issue: 2
Pp: 104-114
Milad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh and Saeed Samarghandian*
DOI: 10.2174/1568009619666191023100046

Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide

Volume:20   Issue: 2
Pp: 115-129
Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa
DOI: 10.2174/1568009619666191021122006

Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization

Volume:20   Issue: 2
Pp: 130-145
Keywan Mortezaee, Masoud Najafi*, Bagher Farhood*, Amirhossein Ahmadi*, Dheyauldeen Shabeeb and Ahmed E. Musa
DOI: 10.2174/1568009619666191019143539

Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter

Volume:20   Issue: 2
Pp: 146-155
Marc Lehmacher*, Antje Stolzenburg and Samuel Samnick
DOI: 10.2174/1568009619666191016145602

CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume:20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220